<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Prudhomme N</submitter><funding>Natural Sciences and Engineering Research Council of Canada</funding><funding>Natural Sciences and Engineering Research Council of Canada (NSERC) - Collaborative Research and Development Grant</funding><funding>J.D. Irving, Limited - Excellence in Cancer Research Fund</funding><funding>Canadian Cancer Society (Atlantic Cancer Research Grant)</funding><funding>Ontario Graduate Scholarship</funding><funding>University of Guelph</funding><funding>Natural Sciences and Engineering Research Council of Canada, Discovery Grant</funding><funding>Mitacs</funding><pagination>2248-2266</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11258984</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(8)</volume><pubmed_abstract>The need for therapeutics to treat a plethora of medical conditions and diseases is on the rise and the demand for alternative approaches to mammalian-based production systems is increasing. Plant-based strategies provide a safe and effective alternative to produce biological drugs but have yet to enter mainstream manufacturing at a competitive level. Limitations associated with batch consistency and target protein production levels are present; however, strategies to overcome these challenges are underway. In this study, we apply state-of-the-art mass spectrometry-based proteomics to define proteome remodelling of the plant following agroinfiltration with bacteria grown under shake flask or bioreactor conditions. We observed distinct signatures of bacterial protein production correspondin</pubmed_abstract><journal>Plant biotechnology journal</journal><pubmed_title>Bacterial growth-mediated systems remodelling of Nicotiana benthamiana defines unique signatures of target protein production in molecular pharming.</pubmed_title><pmcid>PMC11258984</pmcid><funding_grant_id>RGPIN-2020-05822</funding_grant_id><funding_grant_id>CRDPJ 539389‐19</funding_grant_id><funding_grant_id>CRDPJ 539389-19</funding_grant_id><funding_grant_id>707196</funding_grant_id><funding_grant_id>IT25508</funding_grant_id><pubmed_authors>Geddes-McAlister J</pubmed_authors><pubmed_authors>Sproule A</pubmed_authors><pubmed_authors>Krieger JR</pubmed_authors><pubmed_authors>Cossar D</pubmed_authors><pubmed_authors>Overy DP</pubmed_authors><pubmed_authors>Prudhomme N</pubmed_authors><pubmed_authors>Thomson S</pubmed_authors><pubmed_authors>Pastora R</pubmed_authors><pubmed_authors>Murphy JP</pubmed_authors><pubmed_authors>McLean MD</pubmed_authors><pubmed_authors>Zheng E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bacterial growth-mediated systems remodelling of Nicotiana benthamiana defines unique signatures of target protein production in molecular pharming.</name><description>The need for therapeutics to treat a plethora of medical conditions and diseases is on the rise and the demand for alternative approaches to mammalian-based production systems is increasing. Plant-based strategies provide a safe and effective alternative to produce biological drugs but have yet to enter mainstream manufacturing at a competitive level. Limitations associated with batch consistency and target protein production levels are present; however, strategies to overcome these challenges are underway. In this study, we apply state-of-the-art mass spectrometry-based proteomics to define proteome remodelling of the plant following agroinfiltration with bacteria grown under shake flask or bioreactor conditions. We observed distinct signatures of bacterial protein production correspondin</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-03T03:36:26.027Z</modification><creation>2025-05-18T13:26:06.231Z</creation></dates><accession>S-EPMC11258984</accession><cross_references><pubmed>38516995</pubmed><doi>10.1111/pbi.14342</doi></cross_references></HashMap>